Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback